Polymer Capital Management (Us) LLC Biomarin Pharmaceutical Inc Transaction History
Polymer Capital Management (Us) LLC
- $846 Billion
- Q2 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 8,014 shares of BMRN stock, worth $420,494. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,014Holding current value
$420,494% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
679Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.19 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$997 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$828 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$793 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$645 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.75B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...